Bolak Co

Bolak Co OCF Margin

The Operating Cash Flow Margin of Bolak Co (002760.KS) as of Oct 28, 2026 is 14.30 %. In the previous year, Operating Cash Flow Margin was 1.90 % — a change of 652.89% (higher).

OCF Margin

14.30 %

YoY

652.89%

Last updated:

Operating Cash Flow Margin of Bolak Co is 2025 14.30 % . Operating Cash Flow Margin of Bolak Co was 2024 1.90 % . It decreases by 652.89% higher compared to the previous year.

The Bolak Co OCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

OCF Margin
Date
OCF Margin
Jan 1, 2018
10.00 KRW
Jan 1, 2019
4.05 KRW
Jan 1, 2020
5.30 KRW
Jan 1, 2021
2.96 KRW
Jan 1, 2022
5.26 KRW
Jan 1, 2023
3.26 KRW
Jan 1, 2024
1.90 KRW
Jan 1, 2025
14.30 KRW
The Bolak Co OCF Margin history
YEAROCF MarginYoY
14.30 %+652.89%
1.90 %-41.67%
3.26 %-38.12%
5.26 %+77.67%
2.96 %-44.13%
5.30 %+30.87%
4.05 %-59.50%
10.00 %+374.13%
2.11 %-86.18%
15.27 %+48.95%
10.25 %-12.04%
11.65 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bolak Co Stock analysis

What does Bolak Co do? Bolak Co., Ltd. generates revenue through its two core business divisions: food additives and pharmaceutical ingredients. The food additives division produces flavors, colors, botanical extracts, nutraceuticals, white emulsion, antioxidants, emulsifiers, bleaching agents, acidulant, and sweetness products. The pharmaceutical ingredients division manufactures extract powers, fluid extracts, tinctures, protein concentrates, and calcium carboxymethyl cellulose (CMC). Domestic and overseas markets purchase these products, with the company distributing them across both regions. The firm's product portfolio targets food manufacturers and pharmaceutical companies seeking raw materials for their production processes. Bolak Co., Ltd. serves food manufacturers and pharmaceutical companies as its primary customer segments. These segments require specialized ingredients for their product development and production lines. The company's domestic market includes Korean food and pharma firms, while overseas buyers include international food processors and pharmaceutical producers. The firm's product range supports both the food and pharmaceutical industries through direct sales to these end-users. The company's revenue streams are derived from the sale of its manufactured ingredients, with no mention of additional services or licensing. Food additives like white emulsion and antioxidants are sold to food producers, while pharmaceutical ingredients such as protein concentrates and CMC are supplied to drug manufacturers. The business model relies on consistent demand for these raw materials from established industry clients. Bolak Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bolak Co stock

Operating Cash Flow Margin of Bolak Co is 14.30 % in 2025.

Operating Cash Flow Margin of Bolak Co changed from 1.90 % to 14.30 %, representing a 652.89% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Margin Bolak Co since 2006 – with annual values, charts, and detailed analysis.

OCF margin measures the percentage of revenue converted into operating cash flow. It indicates cash generation efficiency from core business operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow Margin's Bolak Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Cash Flow Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Bolak Co

All Key Metrics — Bolak Co